Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · IEX Real-Time Price · USD
1.435
+0.020 (1.41%)
At close: Jul 26, 2024, 4:00 PM
1.370
-0.065 (-4.53%)
After-hours: Jul 26, 2024, 5:08 PM EDT
Spero Therapeutics Market Cap
Spero Therapeutics has a market cap or net worth of $77.47 million as of July 26, 2024. Its market cap has decreased by -2.43% in one year.
Market Cap
77.47M
Enterprise Value
443.77K
1-Year Change
-2.43%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since November 2, 2017, Spero Therapeutics's market cap has decreased from $154.10M to $77.47M, a decrease of -49.73%. That is a compound annual growth rate of -9.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 76.40M | -1.93% |
| Dec 29, 2023 | 77.90M | -13.06% |
| Dec 30, 2022 | 89.60M | -82.69% |
| Dec 31, 2021 | 517.50M | -1.84% |
| Dec 31, 2020 | 527.20M | 186.68% |
| Dec 31, 2019 | 183.90M | 64.34% |
| Dec 31, 2018 | 111.90M | -33.71% |
| Dec 29, 2017 | 168.80M | 9.54% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeyondSpring | 76.97M |
| SCYNEXIS | 76.32M |
| Monogram Orthopaedics | 76.01M |
| Verastem | 74.96M |
| Genelux | 74.54M |
| Connect Biopharma Holdings | 74.39M |
| MDxHealth | 74.33M |
| Milestone Scientific | 74.14M |